Provide me strong parent article for the synopsis for a General surgery resident in Uttar Pradesh India
Reading File
Running Command
python -m markitdown /home/daytona/workspace/attachments/067706c5-e1c1-4f16-aec0…
Running Command
python3 -c " from pptx import Presentation prs = Presentation('/home/daytona/wor…
Running Command
cd /home/daytona/workspace/attachments/067706c5-e1c1-4f16-aec0-ae756adf4b4e/ && …
Running Command
pip install python-pptx --quiet --user 2>&1 | tail -3
Running Command
python3 -c " from pptx import Presentation prs = Presentation('/home/daytona/wor…
Searching PubMed
GB-RADS gallbladder reporting data system malignancy
Searching PubMed
gallbladder wall thickening malignancy ultrasonography diagnosis
Searching the Web
GB-RADS gallbladder reporting data system score malignancy prediction validation study PubMed
Reading Article
PMID: 34851429
Reading Article
PMID: 38550799
Reading Article
PMID: 38686188
Reading Article
PMID: 33177791
Searching PubMed
gallbladder cancer northern India epidemiology incidence
Reading Article
PMID: 32323586
Reading Article
PMID: 35532588
Reading Article
PMID: 12623362
I now have all the information needed. Let me compile the comprehensive response.
Strong Parent Articles for Dr. Adish Jain's GB-RADS Synopsis
Based on the full content of your synopsis (GB-RADS score as predictor of malignancy in gallbladder wall thickening - TMMC Moradabad, 2025-2028), here are the primary "parent" articles that directly support, justify, and frame your study. These are ranked by relevance.
🔵 TIER 1 - Direct Parent Articles (GB-RADS Specific)
1. ⭐⭐⭐ THE Core Parent Article
Gupta P, Dutta U, Rana P, et al.
"Gallbladder reporting and data system (GB-RADS) for risk stratification of gallbladder wall thickening on ultrasonography: an international expert consensus."
Abdominal Radiology (NY). 2022 Feb;47(2):418-431.
PMID: 34851429 | DOI: 10.1007/s00261-021-03360-w
Why this is your primary parent article:
This is the original publication that proposed and defined GB-RADS - the very scoring system your study evaluates. It was developed using a modified Delphi method with an international multidisciplinary committee (radiologists, gastroenterologists, GI surgeons, oncologists, pathologists). It defines all 6 GB-RADS categories (0-5) based on US features: wall symmetry, focal vs. circumferential involvement, layered appearance, intramural cysts/echogenic foci, and liver interface.
Key points to cite from this paper in your synopsis:
- GB-RADS is the first collaborative risk stratification system for gallbladder wall thickening
- Proposed to improve consistency in US interpretation and reporting
- Based on systematic review + expert consensus
- Developed explicitly for non-acute setting (exactly your inclusion criterion)
2. ⭐⭐⭐ Validation and Diagnostic Accuracy of GB-RADS
Soundararajan R, Subramanian P, Gupta P, et al.
"Agreement of Gallbladder Reporting and Data System for Gallbladder Wall Thickening at Ultrasonography: A Multireader Validation Study."
Journal of Clinical and Experimental Hepatology. 2024 Jul-Aug;14(4):101393.
PMID: 38550799 | DOI: 10.1016/j.jceh.2024.101393 | PMC: PMC10966770
Why this is essential:
This is the most recent (2024) validation study of GB-RADS from the same Indian academic group (PGI Chandigarh). Across 414 patients:
- GB-RADS 2: 1.2% malignancy risk
- GB-RADS 3: 37% malignancy risk
- GB-RADS 4: 71.1% malignancy risk
- GB-RADS 5: 89.1% malignancy risk
It confirms GB-RADS works well at the extremes but notes "discriminatory performance of GB-RADS 3 and 4 is low" and calls for larger multicenter prospective studies - precisely the gap your study fills. This paper's conclusion directly justifies your research.
3. ⭐⭐⭐ GB-RADS + Color Doppler in Asian Population
Wang R, Lv L, Li L.
"Diagnostic performance of the gallbladder reporting and data system combined with color doppler flow imaging for gallbladder cancer in the Asian population."
Frontiers in Oncology. 2024;14:1367351.
PMID: 38686188 | DOI: 10.3389/fonc.2024.1367351 | PMC: PMC11056497
Why this matters for your synopsis:
This 2024 Chinese study evaluated GB-RADS in an Asian population (highly relevant given your UP cohort):
- GB-RADS alone: AUC = 0.855, sensitivity 82.5%, specificity 84.6%, accuracy 83.8%
- GB-RADS + CDFI: AUC = 0.965, sensitivity 96.2%, specificity 94.6%
Since your patient population is also Asian, these diagnostic performance metrics provide the benchmark values you can use for your sample size calculation and will allow meaningful comparison in your results section.
🟡 TIER 2 - Background and Contextual Parent Articles
4. ⭐⭐ Imaging Algorithm for Gallbladder Wall Thickening
Gupta P, Marodia Y, Bansal A, et al.
"Imaging-based algorithmic approach to gallbladder wall thickening."
World Journal of Gastroenterology. 2020 Oct 28;26(40):6163-6181.
PMID: 33177791 | DOI: 10.3748/wjg.v26.i40.6163 | PMC: PMC7596646 (Open Access)
Why this matters:
This review from PGI Chandigarh (the same group that developed GB-RADS) provides the full diagnostic algorithm framework for gallbladder wall thickening - covering USG, CT, MRI, CEUS, and EUS. It distinguishes focal vs. circumferential thickening and addresses the specific differential diagnoses (cholecystitis, xanthogranulomatous cholecystitis, adenomyomatosis vs. carcinoma). This is the best paper for your Introduction and Review of Literature sections on imaging approaches.
5. ⭐⭐ Multimodality Imaging Review with Expert Opinion
Gupta P, Kumar M, Sharma V, Dutta U, Sandhu MS.
"Evaluation of gallbladder wall thickening: a multimodality imaging approach."
Expert Review of Gastroenterology & Hepatology. 2020 Jun;14(6):513-525.
PMID: 32323586 | DOI: 10.1080/17474124.2020.1760840
Notably relevant - cite this passage verbatim in your Rationale: The expert opinion section explicitly states: "There is a need for a well-designed reporting system for GB wall thickening to ensure uniformity of reporting of imaging tests, especially in regions with a high prevalence of GB cancer." - This is the sentence that provides the academic mandate for GB-RADS, and by extension, for your study.
🟠 TIER 3 - Epidemiology and Regional Context (Uttar Pradesh Justification)
6. ⭐⭐ Risk Factors in Northern India - Case-Control Study
Mishra K, Behari A, Shukla P, et al.
"Risk factors for gallbladder cancer development in northern India: A gallstones-matched, case-control study."
Indian Journal of Medical Research. 2021 May;153(5 & 6):590-599.
PMID: 35532588 | DOI: 10.4103/ijmr.IJMR_201_19 | PMC: PMC9210525 (Open Access)
Why this matters for a UP resident:
From SGPGI Lucknow (the premier referral center for UP), this matched case-control study confirms the high incidence of gallbladder cancer in northern India and identifies regional risk factors (poor bowel habits, unsafe water, multiparity). This is your strongest local epidemiological citation for justifying why this study needs to be done at a tertiary center in Moradabad, UP.
7. ⭐ Classic Gallbladder Carcinoma Review (Lancet Oncology)
Misra S, Chaturvedi A, Misra NC, Sharma ID.
"Carcinoma of the gallbladder."
Lancet Oncology. 2003 Mar;4(3):167-176.
PMID: 12623362 | DOI: 10.1016/s1470-2045(03)01021-0
Why this is still worth citing:
Published in The Lancet Oncology (highest-impact journal in the field), this remains the classic definitive review cited globally. It establishes that "a particularly high incidence is observed in Chile, Japan, and northern India" and explains that GBC is diagnosed late in disease course due to non-specific symptoms. Despite being from 2003, its epidemiological statements on northern India are still widely cited in Indian surgical theses and papers.
Summary Table for Your Synopsis References Section
| # | PMID | Article | Journal | Year | Role in Your Synopsis |
|---|---|---|---|---|---|
| 1 | 34851429 | GB-RADS International Expert Consensus - Gupta et al. | Abdom Radiol | 2022 | Primary parent - defines GB-RADS itself |
| 2 | 38550799 | GB-RADS Multireader Validation Study - Soundararajan et al. | J Clin Exp Hepatol | 2024 | Justifies gap; provides malignancy % per category |
| 3 | 38686188 | GB-RADS + CDFI in Asian population - Wang et al. | Front Oncol | 2024 | Benchmark diagnostic accuracy for sample size |
| 4 | 33177791 | Imaging algorithm for GBWT - Gupta et al. | World J Gastroenterol | 2020 | Review of Literature - imaging approach |
| 5 | 32323586 | Multimodality imaging GBWT - Gupta et al. | Expert Rev Gastroenterol Hepatol | 2020 | Rationale - calls for standardized reporting system |
| 6 | 35532588 | Risk factors GBC northern India - Mishra et al. | Indian J Med Res | 2021 | Epidemiological justification for UP setting |
| 7 | 12623362 | Carcinoma of the gallbladder - Misra et al. | Lancet Oncol | 2003 | Classic citation for GBC epidemiology |
Two Important Notes for Your Protocol
1. Correct the sample size formula: Your current slide 12 shows a formula for comparing two group means with incomplete values referencing "omega-3 supplements" (likely copied from another synopsis). For a diagnostic accuracy study like yours, the correct formula is:
n = Z²α/2 × P(1-P) / d²
Where P = expected sensitivity/specificity from literature (use ~85% from Wang et al., PMID 38686188), and d = acceptable margin of error (±10%). This will give you a single sample size (no groups), which aligns with your observational design.
2. Study design correction: Slide 11 says "Prospective Randomised Control Trial" - this is incorrect for your study design. It should be "Prospective Observational Study" (diagnostic accuracy/cohort design). There is no randomization or intervention in your study.
This is a shared conversation. Sign in to Orris to start your own chat.